1421 ET - Robert F. Kennedy, Jr.'s latest op-ed on vaccines should give biotechnology companies some hope, Mizuho analysts say. The Secretary of Health and Human Services said in a Sunday opinion piece for Fox News that the latest measles outbreak is a call to action to vaccinate children, which HHS will help facilitate. RFK's pivot to supporting vaccines may mean companies like Vaxcyte that produce them will fare better than investors had worried. Vaxcyte's stock is down 20% over the past three months, primarily driven by political concerns, analysts say. "We continue to believe macro concerns dissipate," analysts said. (katherine.hamilton@wsj.com)
(END) Dow Jones Newswires
March 03, 2025 14:21 ET (19:21 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。